RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GRIMALDI F
Collezione AOU Novara

Items : 5

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Candoni A; Foa R; Ferrara F; Pizzolo G; Bassan R; Starza ID; Fanin R; Luppi M; Marsili G; Vignetti M; Piciocchi A; Mancini V; De Bellis E; Trastulli F; Ciccone M; De Gobbi M; Cignetti A; Mazzone C; Aprile L; Mauro E; Fanin M; Chiusolo P; Minetto P; Defina M; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; et alii...

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas. in Global & regional health technology assessment / Glob Reg Health Technol Assess. 2024 Jan 9;11:1-16. doi: 10.33393/grhta.2024.2601. eCollection 2024

2024
ASL Novara
AOU Novara

Peri A; Minniti G; Maffei P; Locatelli D; Laureti S; Lello S; Lania AG; Ferraù F; Doglietto F; Caputo M; Paoletta A; Bozzao A; Cappabianca P; Vecchi S; Saulle R; Mitrova Z; Cruciani F; Tortora F; Rudà R; Poggi M; Iatì G; Mazzatenta D; Ferrante E; Esposito F; De Menis E; Scoppola A; Auriemma RS; Samperi I; Persichetti A; et alii...

Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2024;24(8):991-1006. doi: 10.2174/0118715303260423231122111

2024
AO Cuneo
ASL Novara
AOU Novara

Attanasio R; Cozzi R; Grimaldi F; Tonzar L; Scillitani A; Pepe J; Palermo A; Minisola S; Miele V; Marcocci C; Mazzaferro S; Madeo B; Lombardi CP; Iannetti G; Laureti S; Falchetti A; De Rimini ML; Corbetta S; Cianferotti L; Cetani F; Calò PG; Novizio R; Samperi I; Scoppola A; Persichetti A; Papini E; Paoletta A; Giovanazzi A; Basile M; et alii...

Italian Guidelines for the Management of Prolactinomas. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2023;23(12):1459-1479. doi: 10.2174/18715303236662305111040

2023
ASL Novara
AOU Novara

Minniti G; Maffei P; Locatelli D; Lello S; Laureti S; Lania AG; Ferraù F; Doglietto F; Caputo M; Bozzao A; Scoppola A; Samperi I; Persichetti A; Paoletta A; Papini E; Cappabianca P; Basile M; Saulle R; Vecchi S; Mitrova Z; Cruciani F; Tortora F; Poggi M; Rudà R; Mazzatenta D; Iatì G; Ferrante E; Esposito F; De Menis E; et alii...

Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study. in Biomedicines / Biomedicines. 2021 Aug 6;9(8):972. doi: 10.3390/biomedicines9080972.

2021
AOU Novara

Lessi F; Laurino M; Papayannidis C; Vitagliano O; Grimaldi F; Lazzarotto D; Gottardi M; Crisà E; Riva M; Reda G; Ermani M; Semenzato G; Trentin L; Ferrara F;